Exon copy-number changes in medically relevant disease genes. Representative results of exon array CGH for patient DNA samples hybridized against a female pool that demonstrates the variety of copy-number changes detected in the present study. All patient samples were fluorescently labeled using Cy5, and all control female-pool samples were fluorescently labeled using Cy3. The features of the plots are as described for figure 2. The gray arrows highlight the copy-number changes. A, Female patient—EA02(260055)—with HNPP showing a deletion of the entire PMP22 gene. B, Male patient—EA07(221358)—with CMT1 showing a duplication of the entire PMP22 gene. C, Male patient (DH/PMD2–1) with PMD showing a triplication of the entire PLP1 gene. D, Female PMD carrier (PMD2–2, mother of patient in panel C) showing a triplication of the entire PLP1 gene. E, Male patient (EA19) with DMD showing a duplication of exon 2 in the DMD gene. F, Male patient (p130) with NF2 showing a deletion of exons 13–15 of the NF2 gene. G, Male patient (EA14) with DMD showing a deletion of exons 3–7 of the DMD gene. Panel also shows the confirmatory PCR results; lanes are numbered according to the exons assayed and size markers (“M”), in base pairs, shown at the left of the gel image. H, Male patient (EA12) with DMD showing the deletion of exon 51 of the DMD gene. Confirmatory PCR is also shown with lanes numbered according to the exons assayed and size markers (“M”), in base pairs, shown at the left.